These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36564531)

  • 1. Corticotropin-Releasing Factor receptor 1 (CRF1) antagonism in patients with alcohol use disorder and high anxiety levels: effect on neural response during Trier Social Stress Test video feedback.
    Lee MR; Rio D; Kwako L; George DT; Heilig M; Momenan R
    Neuropsychopharmacology; 2023 Apr; 48(5):816-820. PubMed ID: 36564531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CRF1 Antagonist Verucerfont in Anxious Alcohol-Dependent Women: Translation of Neuroendocrine, But not of Anti-Craving Effects.
    Schwandt ML; Cortes CR; Kwako LE; George DT; Momenan R; Sinha R; Grigoriadis DE; Pich EM; Leggio L; Heilig M
    Neuropsychopharmacology; 2016 Nov; 41(12):2818-2829. PubMed ID: 27109623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine study.
    Kwako LE; Spagnolo PA; Schwandt ML; Thorsell A; George DT; Momenan R; Rio DE; Huestis M; Anizan S; Concheiro M; Sinha R; Heilig M
    Neuropsychopharmacology; 2015 Mar; 40(5):1053-63. PubMed ID: 25409596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of corticotropin-releasing factor-1 receptors in the infralimbic cortex prevents stress-induced reinstatement of alcohol seeking in male Wistar rats: Evidence of interaction between CRF
    Flores-Ramirez FJ; Matzeu A; Sánchez-Marín L; Martin-Fardon R
    Neuropharmacology; 2022 Jun; 210():109046. PubMed ID: 35341789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a corticotropin-releasing factor receptor 1 antagonist on the fear conditioning response in low- and high-anxiety rats after chronic corticosterone administration.
    Skórzewska A; Wisłowska-Stanek A; Lehner M; Turzyńska D; Sobolewska A; Krząścik P; Szyndler J; Maciejak P; Płaźnik A
    Stress; 2019 Jan; 22(1):113-122. PubMed ID: 30345859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Hypothalamic-Pituitary-Adrenal axis and corticotropin-releasing factor stress system on cue-induced relapse to alcohol seeking.
    Galesi FL; Ayanwuyi LO; Mijares MG; Cippitelli A; Cannella N; Ciccocioppo R; Ubaldi M
    Eur J Pharmacol; 2016 Oct; 788():84-89. PubMed ID: 27316790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of hypothalamic corticotropin-releasing factor in mediating alcohol-induced activation of the rat hypothalamic-pituitary-adrenal axis.
    Rivier C
    Front Neuroendocrinol; 2014 Apr; 35(2):221-33. PubMed ID: 24211830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential neuroendocrine responses to chronic variable stress in adult Long Evans rats exposed to handling-maternal separation as neonates.
    Ladd CO; Thrivikraman KV; Huot RL; Plotsky PM
    Psychoneuroendocrinology; 2005 Jul; 30(6):520-33. PubMed ID: 15808921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The blockade of corticotropin-releasing factor 1 receptor attenuates anxiety-related symptoms and hypothalamus-pituitary-adrenal axis reactivity in mice with mild traumatic brain injury.
    Kosari-Nasab M; Sadeghi T; Bashiri H; Shokouhi G; Salari AA
    Behav Pharmacol; 2019 Apr; 30(2 and 3-Spec Issue):220-228. PubMed ID: 30883392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the CRF
    Epstein DH; Kennedy AP; Furnari M; Heilig M; Shaham Y; Phillips KA; Preston KL
    Psychopharmacology (Berl); 2016 Dec; 233(23-24):3921-3932. PubMed ID: 27595147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing hormone receptors in the medial prefrontal cortex regulate hypothalamic-pituitary-adrenal activity and anxiety-related behavior regardless of prior stress experience.
    Jaferi A; Bhatnagar S
    Brain Res; 2007 Dec; 1186():212-23. PubMed ID: 18001698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The corticotropin-releasing factor (CRF)(1) receptor antagonists CP154,526 and DMP695 inhibit light-induced phase advances of hamster circadian activity rhythms.
    Gannon RL; Millan MJ
    Brain Res; 2006 Apr; 1083(1):96-102. PubMed ID: 16551464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus.
    Flandreau EI; Ressler KJ; Owens MJ; Nemeroff CB
    Psychoneuroendocrinology; 2012 Jan; 37(1):27-38. PubMed ID: 21616602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired hypothalamic-pituitary-adrenal axis and its feedback regulation in serotonin transporter knockout mice.
    Jiang X; Wang J; Luo T; Li Q
    Psychoneuroendocrinology; 2009 Apr; 34(3):317-31. PubMed ID: 18980809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin releasing factor: a key role in the neurobiology of addiction.
    Zorrilla EP; Logrip ML; Koob GF
    Front Neuroendocrinol; 2014 Apr; 35(2):234-44. PubMed ID: 24456850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen Regulation of Corticotropin Releasing Factor Receptor 1 in the Mouse Brain.
    Rybka KA; Sturm KL; De Guzman RM; Bah S; Jacobskind JS; Rosinger ZJ; Taroc EZM; Forni PE; Zuloaga DG
    Neuroscience; 2022 May; 491():185-199. PubMed ID: 35398506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in androgen receptor, estrogen receptor alpha, and c-Fos co-expression with corticotropin releasing factor expressing neurons in restrained adult mice.
    Rybka KA; Lafrican JJ; Rosinger ZJ; Ariyibi DO; Brooks MR; Jacobskind JS; Zuloaga DG
    Horm Behav; 2023 Nov; 156():105448. PubMed ID: 38344954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin-releasing factor (CRF) receptor-1 is involved in cardiac noradrenergic activity observed during naloxone-precipitated morphine withdrawal.
    Martínez-Laorden E; García-Carmona JA; Baroja-Mazo A; Romecín P; Atucha NM; Milanés MV; Laorden ML
    Br J Pharmacol; 2014 Feb; 171(3):688-700. PubMed ID: 24490859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-pain-related CRF1 activation in the amygdala facilitates synaptic transmission and pain responses.
    Ji G; Fu Y; Adwanikar H; Neugebauer V
    Mol Pain; 2013 Feb; 9():2. PubMed ID: 23410057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of early adolescent stress: dysregulation of hypothalamic-pituitary-adrenal axis and central corticotropin releasing factor receptor 1 expression in adult male rats.
    Li C; Liu Y; Yin S; Lu C; Liu D; Jiang H; Pan F
    Behav Brain Res; 2015 Jul; 288():39-49. PubMed ID: 25882722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.